David Westenberg, CFA

David Westenberg is senior research analyst and managing director at Piper Sandler covering animal health and genomics tools and labs. Prior to joining Piper Sandler in 2021, Westenberg was a senior analyst at Guggenheim Securities, covering diagnostics labs, genomic instruments and animal health. Prior to joining Guggenheim, he was a senior analyst at CL King, leading the coverage of diagnostics and animal health. Westenberg is a CFA Charterholder, and was a StarMine runner-up for stock picking in medical equipment in 2018. He has a master’s in finance from Bocconi University in Milan and a Bachelor of Science in business administration from San Francisco State.

Universe Coverage

Genomic Tools and Labs
ADPT	Adaptive Biotechnologies Corp.
AKYA	Akoya Biosciences, Inc.
CTKB	Cytek BioSciences, Inc.
EXAS	Exact Sciences Corporation
FLGT	Fulgent Genetics, Inc.
GH	Guardant Health, Inc.
ILMN	Illumina, Inc.
MYGN	Myriad Genetics, Inc.
NTRA	Natera, Inc.
NEO	NeoGenomics, Inc.
OCX	Oncocyte Corporation
ONT LN	Oxford Nanopore Technologies Plc
PACB	Pacific Biosciences of California, Inc.
DGX	Quest Diagnostics Incorporated

Animal Health
ELAN	Elanco Animal Health, Inc.
IDXX	IDEXX Laboratories, Inc.
NEOG	Neogen Corporation
ZTS	Zoetis, Inc.